Sage Laboratories Inc
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Sage Laboratories Inc stock price vs SLG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SLG's multiple
Needs Revenue / share.
Implied fair value · at Sage Laboratories Inc's multiple
Needs Sage Laboratories Inc P/S.
Engine logicSage Laboratories Incvalued onSLG’smultiple
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Sage Laboratories Inc Latest annual filing · SLG FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 37% equity / 63% debt · EV / Revenue 10.47x · EV / EBITDA 30.34x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAGE LABORATORIES INC · implied price per share
Reporting currency could not be verified.
SL GREEN REALTY CORP · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Sage Laboratories Inc · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
1.83x
Net debt / EBITDA
Leverage against operating earnings
—
18.93x
Cash and equivalents
Liquid reserves on the balance sheet
—
$179.41M
Total debt
Interest-bearing obligations outstanding
—
$6.73B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BXP, Inc.
Sage Laboratories Inc vs BXP
VORNADO REALTY TRUST
Sage Laboratories Inc vs VNO
Paramount Group, Inc.
Sage Laboratories Inc vs PGRE
Empire State Realty Trust, Inc.
Sage Laboratories Inc vs ESRT
COSTAR GROUP, INC.
Sage Laboratories Inc vs CSGP
WELLTOWER INC.
Sage Laboratories Inc vs WELL
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.